Lower Dose Radiation for Prostate Cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether a lower dose of radiation can effectively treat prostate cancer while reducing side effects. It is for men with certain types of prostate cancer that are visible on an MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer confirmed by a biopsy.
- Your cancer is low or intermediate risk (Grade Group 1, 2, or 3).
- Your PSA level is less than 20 ng/mL.
- You have a tumor seen on an MRI that is less than 2.5 cm.
- You have not had radiation or surgery to the prostate before.
- You are willing to fill out questionnaires about your symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a prostate radiation approach given in two treatments, planned using MRI. It’s designed for men with lower-to-intermediate risk prostate cancer and aims to see if this method is safe and works well.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
This trial tests whether men with certain prostate cancer seen on MRI can safely receive a lower dose of radiation. The goal is to keep cancer control while possibly reducing side effects.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
This trial tests whether a shorter course of radiation works as well as the usual longer course for people with high-risk prostate cancer. The goal is to keep cancer control while possibly reducing treatment time and inconvenience.
This trial tests whether a single, high dose of radiation can treat low- to intermediate-risk prostate cancer. It may be a shorter and more convenient option for eligible patients.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.